Product NDC: | 68094-767 |
Proprietary Name: | Lithium Citrate |
Non Proprietary Name: | Lithium Citrate |
Active Ingredient(s): | 8 meq/5mL & nbsp; Lithium Citrate |
Administration Route(s): | ORAL |
Dosage Form(s): | SYRUP |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68094-767 |
Labeler Name: | Precision Dose Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA070755 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090929 |
Package NDC: | 68094-767-62 |
Package Description: | 3 TRAY in 1 CASE (68094-767-62) > 10 CUP, UNIT-DOSE in 1 TRAY > 5 mL in 1 CUP, UNIT-DOSE (68094-767-59) |
NDC Code | 68094-767-62 |
Proprietary Name | Lithium Citrate |
Package Description | 3 TRAY in 1 CASE (68094-767-62) > 10 CUP, UNIT-DOSE in 1 TRAY > 5 mL in 1 CUP, UNIT-DOSE (68094-767-59) |
Product NDC | 68094-767 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Lithium Citrate |
Dosage Form Name | SYRUP |
Route Name | ORAL |
Start Marketing Date | 20090929 |
Marketing Category Name | ANDA |
Labeler Name | Precision Dose Inc. |
Substance Name | LITHIUM CITRATE |
Strength Number | 8 |
Strength Unit | meq/5mL |
Pharmaceutical Classes | Mood Stabilizer [EPC] |